Kami Bhat, Ph.D., is a molecular cancer biologist with over 13 years of experience in managing multiple projects in the field of oncology. They completed their Ph.D. in Biochemistry at Vanderbilt University, where they researched proteins in the DNA damage response and chemoresistance. Kami has held various roles, including being a Principal Scientist at Pfizer and previously at Genentech, focusing on discovery oncology. Their postdoctoral training at Stanford University involved the regulation of carcinogenic pathways, contributing significantly to cancer epigenetics research.
This person is not in any teams
This person is not in any offices